Eligard side effects - from FDA reports


In this review, we analyze Eligard side effects by the time on the drug, gender and age of the people who have side effects while taking Eligard. The review is based on 4,173 people who have side effects while taking the drug from FDA, and is updated regularly.


Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our original studies have been referenced on 400+ peer-reviewed medical publications, including: The Lancet, and Mayo Clinic Proceedings.


Eligard

Eligard has active ingredients of leuprolide acetate. It is often used in prostate cancer. (latest outcomes from Eligard 4,198 users)


On Apr, 17, 2018

4,173 people who take Eligard are studied.


Number of reports submitted per year:

Eligard side effects.

Most common side effects over time *:

< 1 month:
  • Prostatic specific antigen increased
  • Drug ineffective
  • Febrile neutropenia (fever with reduced white blood cells)
  • Death
  • Pulmonary embolism (blockage of the main artery of the lung)
  • Cardiac failure
  • Alanine aminotransferase increased
  • Hyperkalaemia (damage to or disease of the kidney)
  • Neutropenia (an abnormally low number of neutrophils)
  • Ventricular fibrillation (abnormally irregular heart rhythm)
1 - 6 months:
  • Death
  • Terminal state (the transitional states between life and biological death)
  • Hot flush (sudden feelings of heat)
  • Prostatic specific antigen increased
  • Small intestinal obstruction (blockage in small intestine)
  • Toxic skin eruption (skin breakdown due to toxic substance)
  • Pulmonary embolism (blockage of the main artery of the lung)
  • Drug ineffective
  • Hospitalisation
  • Pneumonia
6 - 12 months:
  • Death
  • Prostatic specific antigen increased
  • Prothrombin time abnormal
  • Weight increased
  • Nausea (feeling of having an urge to vomit)
  • Fatigue (feeling of tiredness)
  • Hospitalisation
  • Muscle disorder (muscle disease)
  • Phlebitis (inflammation of the walls of a vein)
  • Pneumonia
1 - 2 years:
  • Death
  • Prostate cancer metastatic
  • Cardiac arrest
  • Hepatitis c
  • Hospitalisation
  • Malaise (a feeling of general discomfort or uneasiness)
  • Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  • Oesophageal adenocarcinoma (a cancer tumour of an epithelium in oesophagus)
  • Prostatic specific antigen increased
  • Ventricular extrasystoles (premature cardiac contraction)
2 - 5 years:
  • Death
  • Hospitalisation
  • Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  • Muscular weakness (muscle weakness)
  • Oedema peripheral (superficial swelling)
  • Prostate cancer metastatic
  • Prostatic specific antigen increased
  • Weight increased
  • Anaemia (lack of blood)
  • Brain neoplasm malignant (brain cancer tumour)
5 - 10 years:
  • Hip fracture
  • Lung neoplasm malignant (cancer tumour of lung)
  • Malaise (a feeling of general discomfort or uneasiness)
  • Death
  • Hospitalisation
  • Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  • Dementia (madness)
  • Disease progression
  • Ear neoplasm (tour in ear)
  • Functional gastrointestinal disorder (functional problem in separate organs of gastrointestinal system)
10+ years:
  • Death
  • Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  • Renal failure (kidney dysfunction)
not specified:
  • Death
  • Prostatic specific antigen increased
  • Terminal state (the transitional states between life and biological death)
  • Hot flush (sudden feelings of heat)
  • Drug ineffective
  • Hospitalisation
  • Weight decreased
  • Vomiting
  • Osteonecrosis of jaw (death of bone of jaw)
  • Pneumonia

Most common side effects by gender *:

female:
  • Focal nodular hyperplasia (tumour of the liver)
  • Weight decreased
  • Neoplasm progression (growth of tumour)
  • Visual impairment
  • Vomiting
  • Brachial plexus injury (brachial plexus injuries, are caused by damage to those nerves network that conducts signals from the spinal cord)
  • Dehydration (dryness resulting from the removal of water)
  • Elevated mood
  • Injection site reaction
  • Nausea (feeling of having an urge to vomit)
male:
  • Death
  • Prostatic specific antigen increased
  • Terminal state (the transitional states between life and biological death)
  • Drug ineffective
  • Hot flush (sudden feelings of heat)
  • Weight increased
  • Weight decreased
  • Injection site pain
  • Osteonecrosis of jaw (death of bone of jaw)
  • Hospitalisation

Most common side effects by age *:

0-1:
  • Xerosis (abnormal dryness of the skin or mucus membranes)
2-9:
  • Focal nodular hyperplasia (tumour of the liver)
  • Psoriasis (immune-mediated disease that affects the skin)
  • Rash
30-39:
  • Elevated mood
  • Weight decreased
40-49:
  • Confusional state
  • Fungal infection
  • Hair growth abnormal
  • Injection site reaction
  • Myalgia (muscle pain)
  • Renal failure (kidney dysfunction)
  • Skin disorder (skin disease)
  • Urinary tract obstruction
50-59:
  • Death
  • Drug ineffective
  • Osteonecrosis of jaw (death of bone of jaw)
  • Prostatic specific antigen increased
  • Toxic optic neuropathy (optic nerve damage caused by toxic (harmful) substances)
  • Alanine aminotransferase increased
  • Hyperkalaemia (damage to or disease of the kidney)
  • Pulmonary embolism (blockage of the main artery of the lung)
  • Terminal state (the transitional states between life and biological death)
  • Urethral haemorrhage (urethral bleeding)
60+:
  • Death
  • Prostatic specific antigen increased
  • Drug ineffective
  • Hot flush (sudden feelings of heat)
  • Osteonecrosis of jaw (death of bone of jaw)
  • Weight decreased
  • Vomiting
  • Hospitalisation
  • Weight increased
  • Pneumonia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have side effects when taking Eligard? Share you experience to help people like you.

Want to find out more about the FDA reports used in the study? You can request them from FDA.

Expand the study to include reports from both FDA and eHealthMe

Eligard side effects from FDA and eHealthMe reports

Related studies

All Eligard side effects from A to Z

a b c d e f g h i j k l m n o p q r s t u v w x y z

On eHealthMe, Eligard (leuprolide acetate) is often used to treat prostate cancer. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:

Related publications that referenced our studies

Analysis tools (to study 684 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

You are not alone. Join our personalized support groups:


Recent updates

General studies
Active Support Groups
Recent Predictions
Personalized studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.